Friday, December 23, 2016 7:09:02 PM
there is no doubt their revenue is probably 200% higher for 4th Qtr over 3rs Qtr for this year, but the potential revenue has come down and is not going to grow at the same rate because of the easing of testing requirements.
Also the testing lab in California will continue at the same rate until 2018, so its inrease in revenue will be at the regular % of 15-20% year or year until it hits 2018, when it can go up.
SGBY has expansion plans, but those are paid through convertible notes and will not allow it to go a lot up as some predict.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM